A new trading day began on Tuesday, with Viking Therapeutics Inc (NASDAQ: VKTX) stock price down -3.81% from the previous day of trading, before settling in for the closing price of $36.0. VKTX’s price has ranged from $18.92 to $79.10 over the past 52 weeks.
During the last 5-year period, the sales drop of Healthcare Sector giant was -23.00%. Meanwhile, its annual earnings per share averaged -168.51%. With a float of $109.62 million, this company’s outstanding shares have now reached $112.45 million.
Viking Therapeutics Inc (VKTX) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Viking Therapeutics Inc is 3.02%, while institutional ownership is 67.21%. The most recent insider transaction that took place on Oct 28 ’25, was worth 216,492. In this transaction Chief Operating Officer of this company sold 6,185 shares at a rate of $35.00, taking the stock ownership to the 382,467 shares. Before that another transaction happened on Oct 27 ’25, when Company’s Director sold 60,000 for $35.57, making the entire transaction worth $2,134,278. This insider now owns 30,000 shares in total.
Viking Therapeutics Inc (VKTX) Earnings and Forecasts
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.32 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.94 per share during the current fiscal year.
Viking Therapeutics Inc (NASDAQ: VKTX) Trading Performance Indicators
Here are Viking Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 28.34.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.12, a number that is poised to hit -0.89 in the next quarter and is forecasted to reach -3.70 in one year’s time.
Technical Analysis of Viking Therapeutics Inc (VKTX)
Looking closely at Viking Therapeutics Inc (NASDAQ: VKTX), its last 5-days average volume was 5.13 million, which is a jump from its year-to-date volume of 4.85 million. As of the previous 9 days, the stock’s Stochastic %D was 55.59%.
During the past 100 days, Viking Therapeutics Inc’s (VKTX) raw stochastic average was set at 60.56%, which indicates a significant increase from 43.35% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 2.29 in the past 14 days, which was higher than the 1.79 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $29.69, while its 200-day Moving Average is $29.28. However, in the short run, Viking Therapeutics Inc’s stock first resistance to watch stands at $36.88. Second resistance stands at $39.13. The third major resistance level sits at $40.26. If the price goes on to break the first support level at $33.50, it is likely to go to the next support level at $32.37. Should the price break the second support level, the third support level stands at $30.12.
Viking Therapeutics Inc (NASDAQ: VKTX) Key Stats
With a market capitalization of 3.91 billion, the company has a total of 113,036K Shares Outstanding. Currently, annual sales are 0 K while annual income is -109,960 K. The company’s previous quarter sales were 0 K while its latest quarter income was -90,790 K.
